PMI Stock Analysis: Buy, Sell, or Hold?
PMI - Picard Medical, Inc.
$3.43
-0.11 (-3.11%)
▼
5d:
+3802.65%
30d:
+2100.13%
90d:
+664.6%
WAIT
LOW Confidence
Analysis Updated: Aug 7, 2026 12:00 AM ET
Earnings: Sep 10, 2026
Get Alerted When PMI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PMI is 22.1% above its trading range ($2.81). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PMI is 22.1% above its trading range ($2.81). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PMI is currently trading at $3.43, which is considered extended relative to its 30-day fair value range of $-0.59 to $2.81.
Technical Outlook: Technically, PMI is showing sideways momentum. Immediate support is located at $0.09, while resistance sits at $5.44. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: PMI scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMI is showing sideways momentum. Immediate support is located at $0.09, while resistance sits at $5.44. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: PMI scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.59 -
$2.81
Company Quality Score
33/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
0.0%
All Signals
- BEARISH: Price significantly overextended (+22.1% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BEARISH: Downward momentum (-3.1%)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.59 -
$2.81
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.09
Resistance Level
$5.44
Current Trend
Sideways
Technical data as of
Aug 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.76
Revenue Growth (YoY)
85.5%
Share & Embed Analysis
Last updated: August 09, 2026 12:45 AM ET
Data refreshes hourly during market hours. Next update: 1:45 AM
Data refreshes hourly during market hours. Next update: 1:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMI showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Michael Patrick O'Shea
BUY
4463 shares
2026-04-24
Piers Godfrey Harrison
BUY
4463 shares
2026-04-24
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 41 HOLD |